Th17 Cells Exhibit Antitumor Effects in MDS Possibly through Augmenting Functions of CD8+ T Cells

Figure 1

Th17 cells expand differentially in L-MDS and H-MDS patients. Lymphocytes were gated by flow cytometry. Representative FACS dot plots of Th17 (CD4+IL-17+) cells from L-MDS, HC, and H-MDS patients (a). Percentages of PB (b) and BM (c) Th17 cells in CD4+ T cells were shown. Percentages of Th17 cells in total T lymphocytes in PB and BM were also shown in (d) and (e), respectively.

(a)

(b)

(c)

(d)

(e)